Literature DB >> 27626781

Perspective: What next for treatment?

Robert J Motzer1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27626781     DOI： 10.1038/537S111a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  Sunitinib in patients with metastatic renal cell carcinoma.

Authors:  Robert J Motzer; Brian I Rini; Ronald M Bukowski; Brendan D Curti; Daniel J George; Gary R Hudes; Bruce G Redman; Kim A Margolin; Jaime R Merchan; George Wilding; Michelle S Ginsberg; Jennifer Bacik; Sindy T Kim; Charles M Baum; M Dror Michaelson
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

Authors:  Robert J Motzer; Thomas E Hutson; Piotr Tomczak; M Dror Michaelson; Ronald M Bukowski; Olivier Rixe; Stéphane Oudard; Sylvie Negrier; Cezary Szczylik; Sindy T Kim; Isan Chen; Paul W Bycott; Charles M Baum; Robert A Figlin
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

3.  Pazopanib versus sunitinib in metastatic renal-cell carcinoma.

Authors:  Robert J Motzer; Thomas E Hutson; David Cella; James Reeves; Robert Hawkins; Jun Guo; Paul Nathan; Michael Staehler; Paul de Souza; Jaime R Merchan; Ekaterini Boleti; Kate Fife; Jie Jin; Robert Jones; Hirotsugu Uemura; Ugo De Giorgi; Ulrika Harmenberg; Jinwan Wang; Cora N Sternberg; Keith Deen; Lauren McCann; Michelle D Hackshaw; Rocco Crescenzo; Lini N Pandite; Toni K Choueiri
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

4.  Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.

Authors:  Robert J Motzer; Bernard Escudier; David F McDermott; Saby George; Hans J Hammers; Sandhya Srinivas; Scott S Tykodi; Jeffrey A Sosman; Giuseppe Procopio; Elizabeth R Plimack; Daniel Castellano; Toni K Choueiri; Howard Gurney; Frede Donskov; Petri Bono; John Wagstaff; Thomas C Gauler; Takeshi Ueda; Yoshihiko Tomita; Fabio A Schutz; Christian Kollmannsberger; James Larkin; Alain Ravaud; Jason S Simon; Li-An Xu; Ian M Waxman; Padmanee Sharma
Journal:  N Engl J Med       Date:  2015-09-25       Impact factor: 91.245
  4 in total
  9 in total

Review 1.  Landscape of Immunotherapy in Genitourinary Malignancies.

Authors:  Deepak Ravindranathan; Omar Alhalabi; Hind Rafei; Amishi Yogesh Shah; Mehmet Asim Bilen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.

Authors:  Jia Wang; Qiujing Zhang; Qingqing Zhu; Chengxiang Liu; Xueli Nan; Fuxia Wang; Lihua Fang; Jie Liu; Chao Xie; Shuai Fu; Bao Song
Journal:  J Cell Physiol       Date:  2019-07-05       Impact factor: 6.384

3.  Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling.

Authors:  Hongzhi Wang; Hanjiang Xu; Quan Cheng; Chaozhao Liang
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

Review 4.  Current evidence on screening for renal cancer.

Authors:  Juliet Usher-Smith; Rebecca K Simmons; Sabrina H Rossi; Grant D Stewart
Journal:  Nat Rev Urol       Date:  2020-08-28       Impact factor: 16.430

5.  miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1.

Authors:  Yongpeng Xie; Luyao Chen; Yu Gao; Xin Ma; Weiyang He; Yu Zhang; Fan Zhang; Yang Fan; Liangyou Gu; Pin Li; Xu Zhang; Xin Gou
Journal:  Cancer Cell Int       Date:  2020-06-10       Impact factor: 5.722

6.  Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients.

Authors:  Annika Fendler; Daniel Bauer; Jonas Busch; Klaus Jung; Annika Wulf-Goldenberg; Severine Kunz; Kun Song; Adam Myszczyszyn; Sefer Elezkurtaj; Bettina Erguen; Simone Jung; Wei Chen; Walter Birchmeier
Journal:  Nat Commun       Date:  2020-02-17       Impact factor: 14.919

7.  Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer.

Authors:  Naveen S Vasudev; Michelle Wilson; Grant D Stewart; Adebanji Adeyoju; Jon Cartledge; Michael Kimuli; Shibendra Datta; Damian Hanbury; David Hrouda; Grenville Oades; Poulam Patel; Naeem Soomro; Mark Sullivan; Jeff Webster; Peter J Selby; Rosamonde E Banks
Journal:  BMJ Open       Date:  2020-05-11       Impact factor: 2.692

8.  Public attitudes towards screening for kidney cancer: an online survey.

Authors:  Laragh L W Harvey-Kelly; Hannah Harrison; Sabrina H Rossi; Simon J Griffin; Grant D Stewart; Juliet A Usher-Smith
Journal:  BMC Urol       Date:  2020-10-28       Impact factor: 2.264

Review 9.  Risk Prediction Models for Kidney Cancer: A Systematic Review.

Authors:  Hannah Harrison; Rachel E Thompson; Zhiyuan Lin; Sabrina H Rossi; Grant D Stewart; Simon J Griffin; Juliet A Usher-Smith
Journal:  Eur Urol Focus       Date:  2020-07-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.